BIOACTIVE PEPTIDE MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2022 to 2030)

Bioactive peptides are a group of biological molecules that are normally buried in the structure of parent proteins and become active after the cleavage of the proteins. Another group of peptides is actively produced and found in many microorganisms. Many groups of bioactive peptides have been marketed chemically or recombinantly. The bioactive peptides are ingredients that provide nutritive value to the food by adding protein and other important nutrients. Bioactive peptides are gaining popularity, owing to health benefits such as prevention and control of chronic disease conditions like cardiovascular disease, diabetes, cancer, and infectious diseases. Therefore, bioactive peptides are used as treatment therapy for most of the functional disorders such as irritable bowel disease, which is expected to drive the market growth.

Market Dynamics

Increasing research and development by key market players for the treatment of pulmonary edema and rheumatoid arthritis is expected to drive growth of the global bioactive peptide market over the forecast period. For instance, on May 30, 2022, APEPTICO Forschung und Entwicklung GmbH, a biotechnology company, announced that the 3-D structure and the mechanism of action of Solnatide,( a dry powder inhalation and an inhaled aerosol formulation of a synthetic peptide) a possible treatment for pulmonary oedema, had been disclosed by an international network of scientists led by APEPTICO.

Similarly, in June 2021, Oryn Therapeutics, a clinical stage biotechnology company, had opened recruitment for rheumatoid arthritis patients for a Phase 1b clinical trial, which was a Randomized, Double-blind, Vehicle Controlled, and Repeat Dose Comparative Study in RA (rheumatoid arthritis) Patients Managed with DMARDs (Disease-modifying antirheumatic drugs), whereas the Phase 1a clinical trial study had been successfully completed in 2020.

Key features of the study:                                          

• This report provides in-depth analysis of the global bioactive peptide market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period: 2022 – 2030, considering 2021 as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
• It profiles key players in the global bioactive peptide market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
• Key players covered as a part of this study include, Archer Daniels Midland Company, Seagarden AS, Phermpep Co. Ltd., Arlak Biotech Pvt. Ltd., Naturade, Royal DSM, MYOS RENS Technology Inc., Natural Factors Inc., Valio Oy, GenScript, HELIX BIOMEDIX, Oryn Therapeutics, Selecta Biosciences, NIBEC, vivitide, PEPTIDE INSTITUTE, INC, BCN Peptides, Setlance srl., APEPTICO Forschung und Entwicklung GmbH, and BIONANOPLUS
• Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
• The global bioactive peptide market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, suppliers, research and consulting firms, new entrants, and financial analysts
• Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global bioactive peptide market

Detailed Segmentation:

• Global Bioactive Peptide Market, By Source:
  • Plant
  • Milk
  • Egg
  • Meat
  • Fish
  • Others (Bacterial Antimicrobial Peptides and Venom Peptidomics)
• Global Bioactive Peptide Market, By Therapeutic Area:
  • Antihypertensive
  • Antioxidant
  • Immunostimulatory
  • Antimicrobial
  • Diabetes
  • Others( Gastrointestinal System and Cardiovascular System)
• Global Bioactive Peptide Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others(Drug Store and Mail-Order Pharmacy)
• Global Bioactive Peptide Market, By Region:
  • North America
    • By Country
      • U.S.
      • Canada
  • Europe
    • By Country
      • U.K.
      • Germany
      • Italy
      • Spain
      • France
      • Russia
      • Rest of Europe
  • Asia Pacific
    • By Country
      • Australia
      • India
      • China
      • Japan
      • ASEAN
      • South Korea
      • Rest of Asia Pacific
  • Latin America
    • By Country
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Middle East
    • By Country
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • By Country/Region
      • South Africa
      • Central Africa
      • North Africa
• Company Profiles
  • Archer Daniels Midland Company*
    • Company Highlights
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Market Strategies
  • Seagarden AS
  • Phermpep Co. Ltd.
  • Arlak Biotech Pvt. Ltd.
  • Naturade
  • Royal DSMConsort Medical plc
  • MYOS RENS Technology Inc.
  • Natural Factors Inc.
  • Valio Oy
  • GenScript
  • HELIX BIOMEDIX
  • Oryn Therapeutics
  • Selecta Biosciences
  • NIBEC
  • vivitide
  • PEPTIDE INSTITUTE, INC
  • BCN Peptides
  • Setlance srl.
  • APEPTICO Forschung und Entwicklung GmbH
  • BIONANOPLUS

 “*” marked represents similar segmentation in other categories in the respective section.